Aspire Biopharma Holdings, Inc. (ASBP) vs HCW Biologics Inc. (HCWB)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and HCW Biologics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.95HealthcareDelayed quote: Oct 6, 2026, 3:31 PM EDT
HCWB
HCW Biologics Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — ASBP vs HCWB
growth of $100 · dividends reinvested · last 4yASBP -99.9% (-83.5%/yr)HCWB -99.8% (-78.4%/yr)HCWB compounded faster over this window
ASBP HCWB
ASBP vs HCWB: by the numbers
- •ASBP is the larger company ($1M vs $561440 market cap).
- •Both run net losses; HCWB's is the smaller (-73.22% vs -11314.24% net margin).
Metrics side by side
Valuation
| Metric | ASBP | HCWB |
|---|---|---|
| P/S ratio | 10.57 | 0.08 |
| P/B ratio | 0.09 | 0.08 |
Profitability
| Metric | ASBP | HCWB |
|---|---|---|
| Gross margin | -1.87% | 20.00% |
| Operating margin | -312016.95% | -20757.65% |
| Net margin | -11314.24% | -73.22% |
| ROE | -93.97% | -66.26% |
| ROIC | -59.81% | -41.92% |
Growth (annualized)
| Metric | ASBP | HCWB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -57.90% |
| Total return CAGR (5Y) | N/A | -69.71% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.